Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 902219 Boston, MA

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,799,832
-$1,111,960 QoQ
Shares Held
626,361
-11.9% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
8 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 70.58118241716838.ToString("F0")% None 29.418817582831625.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. TSHA ranks #97 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,799,832 626,361
2025-12-31 $3,911,792 711,235
2025-09-30 $1,857,379 568,006
2025-06-30 $1,469,085 635,968
2025-03-31 $869,025 625,198
2024-12-31 $1,013,077 585,594
2024-09-30 $931,015 463,192
2020-09-30 $378,313 16,889